Skip to main content
ILDONG HOLDINGS CO.,LTD logo

ILDONG HOLDINGS CO.,LTD — Investor Relations & Filings

Ticker · 000230 ISIN · KR7000230003 KO Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2025-12-22 Transaction in Own Shar…
Country KR South Korea
Listing KO 000230

About ILDONG HOLDINGS CO.,LTD

https://www.ildongholdings.com

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Recent filings

Filing Released Lang Actions
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Results of Disposal of Treasury Shares' (자기주식처분결과보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific number of shares disposed of, the disposal price, the counterparty (Kukje Pharma), and the purpose of the transaction. This falls under the category of a company reporting the sale or disposal of its own shares, which is classified as 'Transaction in Own Shares' (POS).
2025-12-22 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). It details the disposal of treasury shares through a strategic share swap with another company (Kukje Pharma). Since the document specifically reports the company's action of selling/disposing of its own shares, it falls under the 'Transaction in Own Shares' category.
2025-12-19 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 95% confidence The document is a preliminary earnings announcement for the third quarter of 2025, showing consolidated financial results including sales, operating profit, and net income for the period 2025-07-01 to 2025-09-30. It explicitly states these are provisional figures (잠정실적) and includes comparisons to previous quarters and the same period last year. The document is relatively short (2455 characters) and focuses on key financial metrics without detailed financial statements or management discussion. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only. Q3 2025
2025-11-06 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 95% confidence The document is a short announcement (472 characters) about the upcoming disclosure of financial results for the period 2025-01-01 to 2025-09-30, with a scheduled announcement date of 2025-11-06. It explicitly states that the results to be disclosed are preliminary and subject to change after external audit review. The document does not contain actual financial data or detailed financial statements but serves as a notice or alert about the forthcoming financial report. According to the 'MENU VS MEAL' rule, such short notices announcing the timing of a report are classified as Report Publication Announcements (RPA), not as the report itself (like an Interim Report or Annual Report).
2025-11-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates and volumes. This falls under the 'Major Shareholding Notification' category.
2025-09-11 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Ildong Holdings. It details specific transactions (sales) by an individual (Lee Jang-hwi) who is classified as an executive of an affiliate. This type of filing, which reports changes in share ownership by major shareholders or insiders, falls under the 'Major Shareholding Notification' category as it tracks significant ownership changes and threshold updates for the company's major shareholder group.
2025-09-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.